加强健康教育、社会关爱和心理干预

更新于 2026年11月17日 版权声明
三、加强健康教育、社会关爱和心理干预

1.要通过多种形式,广泛开展SARS防治知识的宣传,教育群众提高自我防范意识,配合做好预防、控制工作,并注意针对疫情的变化调整宣传教育重点。

2.充分发挥媒体的舆论导向作用,以宣传防治知识为主,明确群防群治的措施和公众的义务与责任,要真实报道疫情,并要减少有可能引起群众恐慌的报道。

3.心理干预可以通过宣传正确的防治知识来实施,防止歪曲事实、过度紧张和麻痹大意等倾向。SARS是一种在一定条件下传染性很强的疾病,一旦流行,特别是在医务人员及亲属、朋友中出现传播病例甚至死亡病例时,人们会出现各种各样的心理反应,而某些不良心理反应会影响人们的生活质量和身体健康,同时也会影响SARS防治工作的顺利进行。在接诊患者时,医护人员要以友善的态度与患者交流。在患者充分理解的前提下,积极给予心理支持,医护人员的肢体语言,也能给患者增添战胜疾病的力量。对于康复期患者,帮助其打消复发和传染他人的顾虑。对于将要出院的患者,可叮嘱其在出院后2周内暂勿与同事、朋友来往,尽量避免不愉快的事情发生而增加心理负担。

目前尚无有效的疫苗或药物预防方法。

(刘剑芳 严延生)

参考文献

[1]Denison M Woo PC,Lau SK,Lam CS,et al.Discovery of seven novel Mammalia avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus[J].J Virol,2012,86:3995–4008.

[2]Huynh J,Li S,Yount B,et al.Evidence supporting a zoonotic origin of human coronavirus strain NL63[J].J Virol,2012,86:12816–12825.

[3]Ge XY,Li JL,Yang XL,Chmura AA,et al.Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor[J].Nature,2013,503 (7477):535–538.DOI:10.1038/nature12711.

[4]Chan JF,Lau SK,To KK,et al.Middle East respiratory syndrome coronavirus anotherzoonotic betacoronavirus causing SARS-like disease[J].Clin Microbiol Rev,2015,28:65–522.

[5]Center for Disease Control and Prevention.Interim domestic infection control precautions for aerosol-generating procedures on patients with severe acute respiratory syndrome(SARS).[EB/OL].(2003-03-20)[2020-05-05].https://stacks.cdc.gov./view/cdc/25034

[6]Cinatl J,Morgenstern B,Bauer G,et al.Treatment of SARS with human infernos[J].Lancet,2003b,361:2045-2046.

[7]Drosten C,Gunther S,Preiser W,et al.Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J].N Engl J Med,2003,348:1967–1976.

[8]Kathryn V.Holmes.SARS-Associated Coronavirus[J].N Engl J Med,2003,348:1948–1951.

[9]Lee N,Hui D,Wu A,et al.A major outbreak of severe acute respiratory syndrome in Hong Kong[J].N Engl J Med,2003,348:1986–1994.

[10]Lau AC,So LK.Severe acute respiratory syndrome treatment:present status and future strategy[J].Curr opin investing drugs,2003,4:918-920.

[11]Marra MA,Jones SJ,Astell CR,et al.The genome sequence of the SARS-associated coronavirus[J].Science,2003,300:1399-1404.

[12]Peiris JSM,Chu CM,Cheng VCC,et al.Clinical progression an viral load in a community outbreak of coronavirus-associated SARS pneumonia:a prospective study[J].Lancet,2003b,361:1767-1772.

[13]Poutanen SM,Low DE,Henry B,et al.Identification of severe acute respiratory syndrome in Canada[J].N Engl J Med,2003,348:1995–2005.

[14]Rota PA,Oberste MS,Monroe SS,et al.Characterization of a novel coronavirus associated with severe acute respiratory syndrome[J].Science,2003,300:1394-1399.

[15]So LKY,Lau ACW,Yam LYC,et al.Development of a standard treatment protocol for severe acute respiratory syndrome[J].Lancet,2003,361:1615-1616.

[16]Sung J.Clinical diagnosis and management of SARS.WHO Global Conference on Severe Acute Respiratory Syndrome (SARS)[J],wkly Epidemiol Rec,2003,78(34):299-303.

[17]Tsang KW,Ho PL,Ooi GC,et al.A cluster of cases of severe acute respiratory syndrome in Hong Kong[J].N Engl J Med,2003,348:1977–1985.

[18]Thijs Kulken,Ron A M Fouchier,Martin Schutten,et al.Newly Discovered Coronavirus as the primary cause of sever acute respiratory syndrome[J].Lancet,2003,362:263–270.

[19]Thomas G,Ksiazek,D.V.M,Dean Erdman,et al.A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome[J].N Engl J Med,2003,348:1953-1967.(https://www.daowen.com)

[20]Tsang KW,Lam WK.Management of severe acute respiratory syndrome.The Hong Kong University experience[J].Am J Respir Crit Care Med ,2003,168:417-424.

[21]Tsui PT,Kwok ML,Yuen H,et al.Severe acute respiratory syndrome:clinical outcome and prognostic correlates[J].Emerg Infect Dis,2003,9:1064-1069.

[22]Whenhui Li,Michael JM,Natalya V,et al.Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus[J].Nature,2003,426:450-454.

[23]World Health Organization.Summary of probable SARS with onset of illness from 1 November 2002 to 31 July 2003[EB/OL].(2020-09-14).https://www.who.int/csr/sars/country/table2004_04_21/en/

[24]Wong VWS,Dai D,Wu AKL,et al.Treatment of severe acute respiratory syndrome with convalescent plasma[J].Hong Kong Med J ,2003,9:199-201.

[25]World Health Organization.Hospital infection control guidance for severe acute respiratory syndrome (SARS).

[26]Zhao Z,Zhang F,Xu M,et al.Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS)in Guangzhou,PR China[J].J Med Microbiol,2003,52:715-720.

[27]Zhong NS,Zeng GQ.Our strategies for fighting severe acute respiratory failure[J].Am J Respir Crit Care Med,2003,168:7-9.

[28]Kiemer L,Lund O,Brunak S,et al.Coronavirus 3CLpro proteinase cleavage sites:possible relevance to SARS virus pathology[J].BMC Bioinformatics,2004,5 (1):72.

[29]Ho-Sheng Wu,Shu-Chun Chiu,Tsan-Chang Tseng,et al.Serologic and Molecular Biologic Methods for SARS-associated Coronavirus Infection,Taiwan[J].Emerg Infect Dis,2004,10 (2):304-310.DOI:10.3201/eid1002.030731.

[30]Martin Enserink.Interferon shows promise in monkeys[J].Science,2004.303 (5662):1273-1275.

[31]Shannon LE,Dean DE,Michael DB,et al.Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus[J].Emerg Infect Dis,2004,10 (2):311-316.DOI:10.3201/eid1002.030759.

[32]丁彦青.严重急性呼吸综合征的病理学及发病机制[J].解放军医学杂志,2003,28 (6):475-476.

[33]范保星,刘又宁,孟凡义,等.SARS病毒全基因组芯片在临床检测中的应用[J].解放军医学杂志,2003,28 (11):998-1000.

[34]许锐恒.传染性非典型肺炎预防与控制[M].广州:广东教育出版社,2003:5.

[35]吴新伟,程钢,狄飚,等.荧光聚合酶链反应检测严重急性呼吸综合征冠状病毒的方法建立及临床初步应用[J].中华检验医学杂志,2003,26 (5):300-302.

[36]杜普,唐中权,冯铁柱,等.大剂量甘草甜素治疗严重急性呼吸综合征31例[J].内蒙古医学杂志,2004,36 (1):27-28.

[37]杨国良,费小战,陈焕春,等.SARS病毒受体ACE2的克隆、原核表达及其功能区鉴定[J].病毒学报,2006,22 (2):118-122.

[38]刘志伟,胡族琼,赵卫,等.SARS冠状病毒M基因膜内区的克隆、表达与鉴定[J].热带医学杂志,2007,7 (3):215-217。

[39]周丽萍,罗仕伟,贺东生.SARS冠状病毒的分子生物学研究进展[J].生物技术通讯,2006,17 (1):75-77.

[40]李金萍.冠状病毒概述[J].生命科学仪器,2006,5 (1):43-46.

[41]Xie M,Chen Q.Insight into 2019 novel coronavirus- An updated interim review and lessons from SARS-CoV and MERS-CoV[J].Int J Infect Dis,2020,94:119-124.DOI:10.1016/j.ijid.2020.03.071.

[42]Ahmed MS,Amira RK,Asmaa M,et al.Nature as a treasure trove of potential anti-SARSCoV drug leads:a structural/mechanistic rationale[J].RSC Adv,2020,10:19790-19802.DOI:10.1039/d0ra04199h

[43]de Wit E,van Doremalen N,Falzarano D,et al.SARS and MERS:recent insights into emerging coronaviruses[J].Nat Rev Microbiol,2016,14 (8):523-534.DOI:10.1038/nrmicro.2016.81.

✍AI写作